198 related articles for article (PubMed ID: 12002729)
21. A placebo-controlled evaluation of butterbur and fexofenadine on objective and subjective outcomes in perennial allergic rhinitis.
Lee DK; Gray RD; Robb FM; Fujihara S; Lipworth BJ
Clin Exp Allergy; 2004 Apr; 34(4):646-9. PubMed ID: 15080820
[TBL] [Abstract][Full Text] [Related]
22. A randomized control trail of stepwise treatment with fluticasone propionate nasal spray and fexofenadine hydrochloride tablet for seasonal allergic rhinitis.
Takahashi G; Matsuzaki Z; Okamoto A; Ito E; Matsuoka T; Nakayama T; Masuyama K
Allergol Int; 2012 Mar; 61(1):155-62. PubMed ID: 22189593
[TBL] [Abstract][Full Text] [Related]
23. Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis.
Di Lorenzo G; Pacor ML; Pellitteri ME; Morici G; Di Gregoli A; Lo Bianco C; Ditta V; Martinelli N; Candore G; Mansueto P; Rini GB; Corrocher R; Caruso C
Clin Exp Allergy; 2004 Feb; 34(2):259-67. PubMed ID: 14987306
[TBL] [Abstract][Full Text] [Related]
24. Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms.
Martin BG; Andrews CP; van Bavel JH; Hampel FC; Klein KC; Prillaman BA; Faris MA; Philpot EE
Ann Allergy Asthma Immunol; 2006 Jun; 96(6):851-7. PubMed ID: 16802774
[TBL] [Abstract][Full Text] [Related]
25. Montelukast in the treatment of allergic rhinitis: an evidence-based review.
Nayak A; Langdon RB
Drugs; 2007; 67(6):887-901. PubMed ID: 17428106
[TBL] [Abstract][Full Text] [Related]
26. Loratadine provides early symptom control in seasonal allergic rhinitis.
Kaiser HB; Gopalan G; Chung W
Allergy Asthma Proc; 2008; 29(6):654-8. PubMed ID: 18831859
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of loratadine-montelukast on nasal congestion in patients with seasonal allergic rhinitis in an environmental exposure unit.
Day JH; Briscoe MP; Ratz JD; Danzig M; Yao R
Ann Allergy Asthma Immunol; 2009 Apr; 102(4):328-38. PubMed ID: 19441605
[TBL] [Abstract][Full Text] [Related]
28. Effects of monotherapy with intra-nasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis.
Wilson AM; Orr LC; Sims EJ; Lipworth BJ
Clin Exp Allergy; 2001 Jan; 31(1):61-8. PubMed ID: 11167952
[TBL] [Abstract][Full Text] [Related]
29. Montelukast improves symptoms of seasonal allergic rhinitis over a 4-week treatment period.
van Adelsberg J; Philip G; Pedinoff AJ; Meltzer EO; Ratner PH; Menten J; Reiss TF;
Allergy; 2003 Dec; 58(12):1268-76. PubMed ID: 14616102
[TBL] [Abstract][Full Text] [Related]
30. A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma.
Wilson AM; Dempsey OJ; Sims EJ; Lipworth BJ
Clin Exp Allergy; 2001 Apr; 31(4):616-24. PubMed ID: 11359431
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and tolerability of loratadine versus fexofenadine in the treatment of seasonal allergic rhinitis: a double-blind comparison with crossover treatment of nonresponders.
Prenner BM; Capano D; Harris AG
Clin Ther; 2000 Jun; 22(6):760-9. PubMed ID: 10929922
[TBL] [Abstract][Full Text] [Related]
32. Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring.
Philip G; Malmstrom K; Hampel FC; Weinstein SF; LaForce CF; Ratner PH; Malice MP; Reiss TF;
Clin Exp Allergy; 2002 Jul; 32(7):1020-8. PubMed ID: 12100048
[TBL] [Abstract][Full Text] [Related]
33. [Nasal budesonide plus zafirlukast vs nasal budesonide plus loratadine-pseudoephedrine for controlling the symptoms of rhinitis and asthma].
Benitez HH; Arvizu VM; Gutiérrez DJ; Fogelbach GA; Castellanos Olivares A; Vázquez Nava F; Velázquez HC; González Pérez Mdel C; Mora Nieto A; Rodríguez EC
Rev Alerg Mex; 2005; 52(2):90-5. PubMed ID: 16158782
[TBL] [Abstract][Full Text] [Related]
34. A double-blind non-inferiority clinical study of montelukast, a cysteinyl leukotriene receptor 1 antagonist, compared with pranlukast in patients with seasonal allergic rhinitis.
Okubo K; Baba K
Allergol Int; 2008 Dec; 57(4):383-90. PubMed ID: 18946234
[TBL] [Abstract][Full Text] [Related]
35. The effect of montelukast (10mg daily) and loratadine (10mg daily) on wheal, flare and itching reactions in skin prick tests.
Kupczyk M; Kupryś I; Górski P; Kuna P
Pulm Pharmacol Ther; 2007; 20(1):85-9. PubMed ID: 16516511
[TBL] [Abstract][Full Text] [Related]
36. Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis.
van Adelsberg J; Philip G; LaForce CF; Weinstein SF; Menten J; Malice MP; Reiss TF;
Ann Allergy Asthma Immunol; 2003 Feb; 90(2):214-22. PubMed ID: 12602669
[TBL] [Abstract][Full Text] [Related]
37. Montelukast decreased exhaled nitric oxide in children with perennial allergic rhinitis.
Hung CH; Hua YM; Hsu WT; Lai YS; Yang KD; Jong YJ; Chu YT
Pediatr Int; 2007 Jun; 49(3):322-7. PubMed ID: 17532829
[TBL] [Abstract][Full Text] [Related]
38. Intranasal fluticasone propionate versus loratadine in the treatment of adolescent patients with seasonal allergic rhinitis.
Jordana G; Dolovich J; Briscoe MP; Day JH; Drouin MA; Gold M; Robson R; Stepner N; Yang W
J Allergy Clin Immunol; 1996 Feb; 97(2):588-95. PubMed ID: 8621843
[TBL] [Abstract][Full Text] [Related]
39. Montelukast plus cetirizine in the prophylactic treatment of seasonal allergic rhinitis: influence on clinical symptoms and nasal allergic inflammation.
Kurowski M; Kuna P; Górski P
Allergy; 2004 Mar; 59(3):280-8. PubMed ID: 14982509
[TBL] [Abstract][Full Text] [Related]
40. Antiasthmatic effects of mediator blockade versus topical corticosteroids in allergic rhinitis and asthma.
Wilson AM; Orr LC; Sims EJ; Dempsey OJ; Lipworth BJ
Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1297-301. PubMed ID: 11029334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
